SCHEMBL27475656

SCHEMBL27475656

O=C(NCCc1ccccc1)Nc1cc[c]cc1

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CNR1 P21554 4/20 0.68
NPC1 O15118 3/20 0.68
RAB9A P51151 3/20 0.68
SMN1; SMN2 Q16637 1/20 0.68
EPHX1 P07099 3/20 0.65
KDM4E B2RXH2 1/20 0.65
HDAC1 Q13547 2/20 0.63
HDAC2 Q92769 2/20 0.63
CA2 P00918 4/20 0.62
ROCK2 O75116 1/20 0.62
ROCK1 Q13464 1/20 0.62
MAPT P10636 2/20 0.59
KMT2A Q03164 2/20 0.59
FPR2 P25090 1/20 0.59
MEN1 O00255 1/20 0.59
CA12 O43570 3/20 0.58
CA1 P00915 3/20 0.58
CA9 Q16790 3/20 0.58
ALDH1A1 P00352 1/20 0.57
CYP1A2 P05177 1/20 0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4606056 0.89 EPHX1 (0.81) CNR1NPC1RAB9ASMN1; SMN2EPHX1
SCHEMBL4797277 0.84 NPC1 (0.62) NPC1RAB9ASMN1; SMN2KDM4ECA2
SCHEMBL4898196 0.81 KMT2A (0.81) CNR1NPC1RAB9ASMN1; SMN2EPHX1
SCHEMBL10192078 0.81 ALDH1A1 (0.83) CNR1NPC1RAB9ASMN1; SMN2EPHX1
SCHEMBL4897395 0.81 CNR1 (0.74) CNR1NPC1RAB9ASMN1; SMN2EPHX1
SCHEMBL4894746 0.81 CNR1 (1.00) CNR1NPC1RAB9ASMN1; SMN2EPHX1
SCHEMBL5516178 0.81 CNR1 (0.73) CNR1NPC1RAB9ASMN1; SMN2EPHX1
SCHEMBL16857481 0.81 CNR1 (0.73) CNR1NPC1RAB9ASMN1; SMN2EPHX1
SCHEMBL14280558 0.81 CNR1 (0.76) CNR1NPC1RAB9ASMN1; SMN2EPHX1
SCHEMBL4637408 0.80 CNR1 (0.71) CNR1NPC1RAB9ASMN1; SMN2EPHX1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1149869-A Substituted sulfonamides as selective beta3 agonists for treatment of diabetes and obesity MERCK & CO LTD (US) 1997-05-14 CN disclosed